Lee Danner & Bass Inc. Invests $27,000 in Integer Holdings Co. (NYSE:ITGR)

Lee Danner & Bass Inc. acquired a new position in Integer Holdings Co. (NYSE:ITGR) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 200 shares of the medical equipment provider’s stock, valued at approximately $27,000.

Several other hedge funds have also recently made changes to their positions in ITGR. Raymond James Financial Inc. bought a new position in shares of Integer in the 4th quarter worth about $38,073,000. Eagle Asset Management Inc. bought a new position in shares of Integer in the 3rd quarter worth about $14,403,000. Laurus Investment Counsel Inc. acquired a new stake in shares of Integer in the 4th quarter valued at about $5,422,000. New York State Common Retirement Fund grew its stake in shares of Integer by 20.9% in the 4th quarter. New York State Common Retirement Fund now owns 232,569 shares of the medical equipment provider’s stock valued at $30,820,000 after buying an additional 40,158 shares during the period. Finally, Bamco Inc. NY grew its stake in shares of Integer by 17.4% in the 3rd quarter. Bamco Inc. NY now owns 254,377 shares of the medical equipment provider’s stock valued at $33,069,000 after buying an additional 37,700 shares during the period. 99.29% of the stock is owned by institutional investors.

Integer Price Performance

ITGR stock opened at $115.07 on Monday. The company has a market capitalization of $3.87 billion, a P/E ratio of 34.25, a price-to-earnings-growth ratio of 1.72 and a beta of 1.24. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. Integer Holdings Co. has a 52-week low of $107.11 and a 52-week high of $146.36. The business has a 50-day simple moving average of $132.59 and a two-hundred day simple moving average of $132.38.

Integer (NYSE:ITGR) last posted its earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 EPS for the quarter, missing the consensus estimate of $1.46 by ($0.03). Integer had a return on equity of 11.65% and a net margin of 6.92%. The firm had revenue of $449.50 million for the quarter, compared to the consensus estimate of $446.28 million. Research analysts expect that Integer Holdings Co. will post 6.01 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

ITGR has been the subject of several research reports. Truist Financial raised their target price on Integer from $147.00 to $163.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Citigroup raised their target price on Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research note on Wednesday, December 11th. Benchmark raised their target price on Integer from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Friday, February 21st. KeyCorp raised their target price on Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Finally, Wells Fargo & Company restated an “overweight” rating and issued a $160.00 target price on shares of Integer in a research note on Tuesday, December 3rd. Two analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, Integer has a consensus rating of “Moderate Buy” and a consensus target price of $149.00.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.